JohnsonandJohnson | Financial Buzz

Investing News Market News Pharmaceutical The Market Buzz

Johnson & Johnson CEO to Step Down in January

Rebecca Urena08/20/202108/20/2021

2291

Johnson & Johnson (NYSE: JNJ) announced Thursday that CEO Alex Gorsky would be stepping down in January. Gorsky will continue his role in the company as executive chairman, according...

Healthcare Investing News Market News The Market Buzz Travel

United Airlines Enforces Covid Vaccine Mandate

Rebecca Urena08/06/2021

2264

United Airlines (NASDAQ: UAL) is requiring that all U.S. employees get vaccinated against Covid19 by October 25 or face the risk of being terminated. The company is one of...

Biotechnology Healthcare Investing News Market News Medical Use Pharmaceutical Products The Market Buzz

Johnson & Johnson Reports Better-than-Expected Earnings

Rebecca Urena07/21/202107/21/2021

2837

Johnson & Johnson (NYSE: JNJ) released its second-quarter financial results on Wednesday, with earnings and revenue surpassing Wall Street expectations. The company now anticipates to sell USD2.5 Billion of...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

FDA to Place Warning on J&J Covid-19 Vaccine Regarding Rare Disorder

Rebecca Urena07/13/202107/13/2021

4113

The Food and Drug Administration (FDA) revealed it would be placing a warning on the Johnson & Johnson Covid-19 (NYSE: JNJ) vaccine, as the shot has been associated with...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

J&J CEO Reveals that Annual Covid Vaccines May be Necessary

Rebecca Urena06/09/202106/09/2021

2310

Johnson & Johnson (NYSE: JNJ) CEO Alex Gorsky said Wednesday that people will probably need to receive various Covid-19 vaccine doses in addition to their annual flu shot for...

Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Johnson & Johnson’s Appeal Rejected by Supreme Court

Rebecca Urena06/01/202106/01/2021

2447

The Supreme Court denied Johnson & Johnson’s (NYSE: JNJ) appeal to undo a USD2.1 Billion award regarding allegations that its talc powder products contained asbestos, which caused ovarian cancer...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

UK Authorizes Janssen Covid Vaccine for Use

Rebecca Urena05/28/202105/28/2021

2021

Johnson & Johnson’s (NYSE: JNJ) Janssen Covid-19 vaccine was approved by the U.K.’s medicines regulator on Friday. According to Britain’s Medicines and Healthcare products Regulatory Agency, the shots should...

Biotechnology Healthcare Investing News Market News Medical Use Pharmaceutical Products The Market Buzz

Johnson & Johnson Reports Q1 Earnings Topping Consensus Forecast

Rebecca Urena04/20/202104/20/2021

2672

Johnson & Johnson (NYSE: JNJ) reported USD100 Million in first-quarter sales from its Covid-19 vaccine on Tuesday. The company topped the consensus forecast and upped its 2021 earnings forecast....

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Emergent BioSolutions Asked to Halt Covid-Vaccine Production by FDA

Rebecca Urena04/19/2021

2073

Emergent BioSolutions (NYSE: EBS) has been asked by the Food and Drug Administration to stop production for Covid-19 vaccines. According to the company, the halt comes amid a botched...

Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

FDA Suspends Use of Johnson & Johnson Covid Vaccine

Rebecca Urena04/13/2021

3590

Johnson and Johnson’s (NYSE: JNJ) Covid-19 vaccine was halted by the Food and Drug Administration on Tuesday “out of an abundance of caution” after six women were diagnosed with...

Tag: JohnsonandJohnson

Johnson & Johnson CEO to Step Down in January

United Airlines Enforces Covid Vaccine Mandate

Johnson & Johnson Reports Better-than-Expected Earnings

FDA to Place Warning on J&J Covid-19 Vaccine Regarding Rare Disorder

J&J CEO Reveals that Annual Covid Vaccines May be Necessary

Johnson & Johnson’s Appeal Rejected by Supreme Court

UK Authorizes Janssen Covid Vaccine for Use

Johnson & Johnson Reports Q1 Earnings Topping Consensus Forecast

Emergent BioSolutions Asked to Halt Covid-Vaccine Production by FDA

FDA Suspends Use of Johnson & Johnson Covid Vaccine

ABOUT US

Tweets